Navigation Links
Nephros Announces Completion of $3.2 Million Financing Through Rights Offering and Private Placement Transactions
Date:3/10/2011

RIVER EDGE, N.J., March 10, 2011 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today announced the completion of its rights offering and private placement that together resulted in gross proceeds of approximately $3.2 million to Nephros.  The aggregate net proceeds received by Nephros from the rights offering and private placement are estimated to be approximately $2.3 million, after deducting the estimated aggregate expenses of these transactions, the repayment of the $500,000 note, plus all accrued interest thereon, issued to Lambda Investors, LLC, Nephros' largest stockholder, in September 2010 in connection with its loan to Nephros, the payment of an 8% sourcing/transaction fee ($40,000) in respect of the note and an aggregate of $100,000 for reimbursement of Lambda Investors' legal fees incurred in connection with the loan and the rights offering.

"Nephros is pleased to have successfully closed the shareholders rights offering and related private placement financing," said James S. Scibetta, Chairman of Nephros.  "The net proceeds from these transactions will provide Nephros with funds to pursue the further development and commercialization of our filtration products."

Nephros' stockholders subscribed for 99,297,082 units in its previously announced rights offering and Nephros accepted all basic subscription rights and oversubscription privileges.  The units were sold at a per unit purchase price of $0.02.  Gross proceeds to Nephros from the sale of these units in the rights offering was approximately $2.0 million.  Nephros issued an aggregate of 99,297,082 shares of its common stock and warrants to purchase an aggregate of approximately 91.8 million shares of its common stock to stockho
'/>"/>

SOURCE Nephros, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nephros Announces $3.2 Million Financing Through Completion of Rights Offering and Private Placement Transactions
2. Nephros Extends Rights Offering
3. Nephros Has Commenced Rights Offering
4. Nephros Rights Offering Registration Statement Declared Effective
5. Nephros Reports 2010 Third Quarter Financial Results
6. Nephros Completes Bridge Financing and Announces Stockholder Rights Offering
7. Nephros Reports 2010 Second Quarter Financial Results
8. Nephros Receives Formal Response from FDA for 510(k) Application for Hemodiafiltration System
9. Nephros and AmeriWater Announce Dual Stage Ultrafilters to be a Standard Component of MRO Series Water Treatment Systems
10. Nephros Reports 2010 First Quarter Financial Results
11. Nephros Signs Development Agreement with STERIS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 2014  ConvaTec, a privately-held medical products and technologies ... Interim Chief Executive Officer of the company, effective December ... Berger .  "The Board of Directors of ConvaTec thanks ... the past three years," said Magnus Lundberg , ... confident that the company is well positioned for the ...
(Date:12/22/2014)... STOCKHOLM , Dec. 22, 2014 ... Pharmaceuticals, Inc. today announced that the Committee for Medicinal ... Agency (EMA) has adopted a positive opinion for the ... of adult men with Peyronie,s disease with a palpable ... at the start of therapy. The use ...
(Date:12/22/2014)... , Dec. 22, 2014  Mark Farrah Associates ... providing a summary of the 2015 marketplace exchange ... trends.  According to a recent ... and Evaluation, Department of Health and Human Services) ... in individual medical plans through the Marketplace as ...
Breaking Medicine Technology:ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Insights into the Marketplace and Individual Market Growth 2
... DNDN ) announced today that the U.S. ... its New Jersey manufacturing facility, allowing the company to ... meet the needs of patients with asymptomatic or minimally ... Last April, upon receiving FDA approval of ...
... DIEGO, March 10, 2011 Imaging Healthcare Specialists ... GE Discovery ST PET/CT system at its Laurel imaging facility ... now offers state-of-art PET/CT imaging at two locations, in Hillcrest ... (PET) scanner with a multi-slice Computed Tomography (CT) scanner and ...
Cached Medicine Technology:Dendreon Expands Launch of PROVENGE 2Dendreon Expands Launch of PROVENGE 3Dendreon Expands Launch of PROVENGE 4Dendreon Expands Launch of PROVENGE 5GE Discovery ST Installed at Imaging Healthcare Specialists 2
(Date:12/25/2014)... Product liability lawsuits filed in the ... http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal court, ... in the U.S. District Court, Northern District of Ohio ... conference on January 7, 2015, at the Paul G. ... Palm Beach, Florida. The Conference is scheduled to begin ...
(Date:12/25/2014)... 25, 2014 The short film “Color of ... in honor of a true 9/11 hero, Welles Remy Crowther. ... including the 24 hours of Nuremberg International Short Film Festival ... , Actress, screenwriter and director Luciana Lagana plays ... together with her husband, Gregory Graham - Graham ...
(Date:12/25/2014)... 25, 2014 When head lice hits a ... a frenzy to get rid of it while keeping it ... Coral Gables now have the solution right in their neighborhood: ... location, Lice Troopers provides full spectrum head lice screening and ... area, including Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest ...
(Date:12/25/2014)... common during the holidays, but there are strategies that can ... arrive at a party hungry. It may seem logical to ... party, but deprivation leads to hunger, and hunger leads to ... Mount Kisco, N.Y., said in a hospital news release. ... to have a snack before attending a party when you ...
(Date:12/25/2014)... 25, 2014 Thousands of transvaginal mesh ... in a number of multidistrict litigations currently underway in ... Liebhard LLP reports. According to an Order issued on ... a Joint Status Conference in all of the proceedings ... been directed to submit a proposed agenda to the ...
Breaking Medicine News(10 mins):Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4
... lumpectomy linked to depression, fear, study finds , , WEDNESDAY, ... who opt for breast-conserving cancer surgery say they now ... their quality of life, a new study says. , ... were twice as likely to fear their cancer returning ...
... jump in number of those over 70 who are ,doing ... comes to sex, grandma and grandpa are having more of ... the study, the last quarter century has seen a dramatic ... whether married or unmarried. And as an added bonus, seniors ...
... MLAB ) announced today that it has been ... of the 100 fastest-growing,publicly held small companies in the ... with annual revenues of less than $200 million and,rank ... and stock,performance over the past three years. This was ...
... -- China Medicine,Corporation (OTC Bulletin Board: CHME; ... leading distributor and developer of ethical and,over-the-counter ... supplements, medical devices, and medical formulations in ... that it released a white,paper on Recombinant ...
... 9 Nyer Medical Group,Inc. (Nasdaq: NYER ... Medical Supplies,Inc., ("ADCO South") its Florida Medical-Surgical division. ... was awarded a two-year,contract with Sunrise Senior Living, ... 16 of the company,s Assisted Living Facilities in,Massachusetts. ...
... Texas, July 9 SKINTASTIC(TM),Medical and Surgical Rejuvenation ... FDA-approved EVOLENCE(R) -- the latest injectable collagen filler,in ... EVOLENCE(R) boasts immediate, predictable visible results, with little,swelling. ... EVOLENCE(R) in a,comparison study against a popular dermal ...
Cached Medicine News:Health News:Breast-Conserving Surgery Leaves Many Cancer Patients Disappointed 2Health News:Seniors Having More Sex Than Ever 2Health News:Seniors Having More Sex Than Ever 3Health News:Mesa Laboratories, Inc. Named to Fortune Small Business Magazine's 2008 List 2Health News:China Medicine Releases White Paper on Developing Recombinant Aflatoxin-Detoxifizyme 2Health News:Nyer Medical Group, Inc. Announces Sale of Company's Florida Medical-Surgical Division; Pharmacy Division Awarded Two-Year Preferred Supplier Contract 2Health News:Nyer Medical Group, Inc. Announces Sale of Company's Florida Medical-Surgical Division; Pharmacy Division Awarded Two-Year Preferred Supplier Contract 3Health News:New Injectable Collagen Filler Offers Natural Results 2
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
2.5% Soytone, 4.8% Yeast Extract, 0.025% Magnesium Sulfate, 130mM Calcium Chloride....
... pH: pH(4.7%, H 2 O): 7.0 ... 47% Potassium Phosphate Dibasic: 25% Potassium Phosphate Monobasic: ... powder per liter of purified water. Autoclave. Application: ... proteins than LB media by allowing for greater ...
...
Medicine Products: